Abstract
Scope:
In our previous study focused on in vitro interactive effect of Fusarium mycotoxins deoxynivalenol (DON) and fumonisin B1 (FB1), we reported that these toxins tested at low level and in association could lead to additive or synergistic cytotoxic effect. The aim of the present study is to confirm those findings by in vivo study.
Materials and Methods:
Swiss mice were orally administered with low doses of DON (45 μg/kg bw/day), FB1 (110 μg/kg bw/day), and their mixture (DON + FB1) for 7 days.
Results:
As results, no death or abnormal symptoms were observed in all groups. The significant of loss of weight was observed in females group treated with FB1 and its association with DON. Serum chemistry examinations revealed that disorders in lipid metabolism, renal filtration perturb and a rhabdomyolysis. DON has been found as particular inducer of kidney cell deoxyribonucleic acid (DNA) methylation and blood lymphocytes cell death as measured by lymphocytes DNA fragmentation. Female mice were more sensitive and the mixture of DON and FB1 led to additive or more than additive effect particularly for their target kidney which showed different pattern of toxicity.
Conclusion:
Based on the results of this study, the no-observed-adverse effect level (NOAEL) o both DON and FB1 should be low than 45 μg/kg bw/day and 110 μg/kg bw/day, respectively in mice.
Keywords: Combined effect, Fusarium toxins, mice
INTRODUCTION
Mycotoxins are secondary metabolites produced by different fungal species that can contaminate agricultural commodities in fields, during harvest and/or in storage, and can reach human beings through contaminated food. Aflatoxin, ochratoxin A, patulin, and the Fusarium toxins are well-investigated mycotoxins because of their prevalence in agricultural commodities. Plant fusariose is recognized as a great agricultural problem, due to the variety of mycotoxins Fusarium species can produce, including trichothecens, zearalenone, and fumonisins; which have been identified as important contaminants in foodstuffs.[1,2] Since, Fusarium mycotoxins are often found in combination in infested cereal grains, several studies have been focused on their interactive effect in human or animal cells lines.[3,4,5] Thus, it has been demonstrated that the toxic effect of mixtures of mycotoxins could be greater than the single mycotoxins. For example, in our previous study focused on mixture of deoxynivalenol (DON) and fumonisin B1 (FB1), using several endpoints such as lipid peroxidation, protein and deoxyribonucleic acid (DNA) synthesis, cell viability, DNA methylation, and DNA fragmentation; we have reveled FB1 and DON display synergistic or additive effects in lipid peroxidation, inhibition of protein synthesis, and DNA methylation and fragmentation.[5] DON and FB1 are known to cause numerous toxic effects in animals and human exposed via diet.[5]
DON produced abundantly by Fusarium graminearum[6] when ingested, can induce a decrease in food intake or refusal to eat food, vomiting, and digestive disorders; with subsequent losses of weight gain in animals who ingest this mycotoxin.[7] The gastrointestinal system is the target organ of the toxin.[8] DON induced hematological effects, lesions in the nonglandular stomach, and caused thymic lymphoid depletion, increased incidences, and mean severity of spleenic hematopoiesis, and increased mean severity of sternal bone marrow adipocyte deposition in rats at the highest dose.[9]
FB1 causes equine leukoencephalomalacia, porcine pulmonary edema, nephrotoxicity, hepatotoxicity, cardiotoxicity, and hepatocarcinogenicity in laboratory animals and of esophageal carcinoma in humans.[6] It had been reported hepatotoxicity and nephrotoxicity in lambs, rabbits, and mink, as well as an increased rate of apoptosis in liver and kidney.[10,11]
According to our previous in vitro study in human intestinal cells line Caco-2, combination of FB1 and DON lead always to toxic effect greater than FB1 or DON alone.[5] In addition, although each component has been shown to cause tissue toxicity in experimental animal, there is no evidence regarding the effect of mixture of DON and FB1 in vivo. For example, DON and FB1 could exert their in vivo toxic effect on the same target. So the aim of the present study is to determine whether association of DON and FB1 cause an additive or synergistic toxic effect on their systemic targets in mice.
MATERIALS AND METHODS
Materials
Chemicals
DON and FB1 were obtained from Sigma Chemical Company (St Louis, MO, USA) and were dissolved in ethanol/water (50:50). All other chemicals used were of analytical grade. For the study, the mix solvents (ethanol/water) was dried under an air stream at 50°C and reconstituted in water which became the vehicle in the experimentation.
Animals
Male and female Swiss mice (7-8 week old), weighing between 20 and 25 g were obtained from Society of DEPRE (France). Mice were housed in environmentally protected transparent polypropylene cages with stainless steel wire tops for a period of 1 week before induction of different treatments. The mice had free access to water. Experimental diets were placed in special containers to minimize spillage. Environmental conditions included 23-25°C, relative humidity of 45-55%, and a 12-h light: dark cycle. The protocol for this study was approved by the Committee of Bioethics of Nangui Abrogoua University, Abidjan, Ivory Coast.
Methods
Forty mice (20 male and 20 female) were divided into four groups (n = 10 per group with five female + five male): (a) Normal control group, mice received water; (b) DON dosed group, mice received 45 μg/kg bw/day of DON; (c) FB1 dosed group, mice received 110 μg/kg bw/day of FB1 ; and (d) DON + FB1 dosed group, mice receive 45 (DON) + 110 (FB1) μg/kg bw/day. Each group received the appropriate vehicle (water), DON, FB1, or DON + FB1 daily by oral administration for 7 days. Every day the weight of the mice was observed using a Sartorius balance (ED 224S Germany) with 0.0001 mg accuracy. Urine samples were collected refrigerating metabolic cages (Tecniplast, Buguggiate, Italy) and at the end of the experiment, the mice were sacrificed to collect serum and tissues.
Assay for serum and urine chemistry
The serum biochemistry parameters including aspartate aminotransferase (AST), alanine aminotransferase (ALT), total protein (TP), triglyceride (TG), total cholesterol (TC), creatinine, gamma glutamyl transpeptidase (γ-GT) and creatine kinase (CK) were evaluated spectrophotometrically, using commercially available diagnostic kits supplied by BioMerieux (France). Similarly, unary TP and creatinine were evaluated spectrophotometrically using commercially available diagnostic kits supplied by BioMerieux (France).
Renal DNA methylation
The DNA methylation examination was performed as previously described with okadaic acid.[12] DNA was extracted using the Wizard genomic extraction kit (Promega, France) which is designed for isolation of DNA from white blood cells, tissue culture cells and animal tissue, plant tissue, yeast, and gram positive and gram negative bacteria. Then, DNA was quantified by ultraviolet (UV) spectrophotometry at 254 nm. Ten micrograms of purified DNA dissolved in 10 ml of water was incubated at 100°C for 2 min and then treated with 1 ml of 250 mM potassium acetate buffer (pH 5.4), 1 ml of 10 mM zinc sulfate, and 2 ml of nuclease P1 (6.25 U/ml; Sigma, France) overnight at 37°C, and then treated with 2 ml 0.5 M Tris-HCl (pH 8.3), plus 2 ml of the buffer containing alkaline phosphatase (0.31 U/ml). This mixture was incubated at 37°Celsius (37°C) for 2 h. Analysis of DNA base composition was performed on an Instrumentation Consommable Service (ICS; Toulouse, France) chromatograph equipped with a UV Spectra Focus 3-D at room temperature using a C18-phenyl-nucleosyl column (250 × 3.4 mm). Elution was carried out with 6.5 mM H2PO4 (NH4), pH 3.95, and 4% (v/v) methanol at a flow rate of 1 ml/min. Eluates were monitored at 254 nm. Standard bases (dC, dT, dG, dA) (100 mg/ml) and m5dC (10 mg/ml) were obtained from Sigma Chemical and used for quantification, after sequential injection into the high-performance liquid chromatography (HPLC) system. The surface under the curve adjusted to the known concentration of each base was used with computer aided software (Pic3, ICS, France) to quantify the bases. The results in micrograms were used to calculate the rate in percentage of m5dC as compared to m5dC + dC × 100. These rates were presented as mean of the four independents experiments ± standard error of mean (SEM), prior to statistical analysis.
Evaluation of blood lymphocytes DNA fragmentation induced by DON
For agarose gel electrophoresis, genomic DNA was isolated from 300 μl of blood using the Wizard® Genomic DNA Purification Kit as previously described. According to manufacturer's instructions, the isolation of DNA from white blood cells, involves firstly lysis of the red blood cells in the cell lysis solution, followed by lysis of the white blood cells and their nuclei in the nuclei lysis solution. A ribonuclease (RNase) digestion was carried out by addition of RNase solutions. The cellular proteins are then removed by a salt precipitation step, which precipitates the proteins but leaves the high molecular weight genomic DNA in solution. Finally, the genomic DNA is concentrated and desalted by isopropanol precipitation. The DNA was collected by centrifugation (13,000 g) dissolved in DNA rehydrating solution. Total DNA was quantified using the ratio of absorbance at 260/280. Qualitative evaluation of DNA fragmentation was carried out by electrophoresis of the DNA in 1% agarose gel containing ethidium bromide (60 V, 1 h).
Statistical analyses of data
Results are presented as mean ± SEM and analyzed using a nonparametric statistical test, Mann-Whitney test for significance of differences. Acceptable limit is set from P = 0.05*.[13]
RESULTS
Evolution of the weight of mice
During the study, no remarkable changes in general appearance were observed and all mice survived until scheduled necropsy. Likewise, we observed significant differences in body weight of male mice between control and treatment group only at day 3 (D3) but there were no significant differences at day 7 (D7) [Figure 1a]. In females, body weight significantly decreased in mice administrated with DON, FB1, or their combination during the 7 days of mice treatment [Figure 1b].
Figure 1.

Evolution of body weight (g) after oral treatment mice by deoxynivalenol (DON; 45 μg/kg bw/day), fumonisin B1 (FB1; 110 μg/kg bw/day) and their mixture; P < 0.05 (*) with (a) for males mice and (b) females mice
Serum and urine chemistry
The results of biochemical examinations were summarized in Tables 1 and 2. TGs and TC were significantly increased in mice treated with mycotoxins DON or FB1 or their mixture only for male mice in contrast to female mice in which there were no remarkable changes [Tables 1 and 2]. FB1 provoked an increasing of level of blood TPs in male mice, but a decreasing of those of both unary creatinine and TPs in males and females mice [Table 3]. DON increased the level of blood creatinine in both females and males mice, but CK only in male mice. The mixture of DON and FB1 leaded to an increasing of blood TPs and creatinine, but a decreasing of unary creatinine in both males and females. In addition, DON + FB1 increased blood AST level (very notably) and ALT (slightly) only in female mice.
Table 1.
Blood parameters for male mice after oral treatment by DON (45 μg/kg bw/day), FB1 (110 μg/kg bw/day), and their mixture; P<0.05(*)

Table 2.
Blood parameters for females mice after oral treatment by DON (45 μg/kg bw/day), FB1 (110 μg/kg bw/day), and their mixture; P<0.05(*)

Table 3.
Unary creatinine and total proteins for females and males mice after oral treatment by DON (45 μg/kg bw/day), FB1 (110 μg/kg bw/day), and their mixture; P<0.05 (*)

Effects of mycotoxins on DNA methylation in kidney cells
Methylation of deoxycytosine (percentage of m5dC) in the DNA of kidney cells was evaluated by HPLC-UV method in the presence of individual toxin (DON, FB1) and their mixture (FB1 + DON). DON alone slightly increased the level of m5dC from 3.6 to 4.07%, but not FB1. Interestingly, association of FB1 and DON increased level of m5dC from 3.6 to 7.2% [Figure 2].
Figure 2.

Deoxyribonucleic acid (DNA) methylation as measured by determination of the ratio m5dC on (dC + m5dC) × 100 in the DNA of kidney cells after oral administration of DON (45 μg/kg bw/day), FB1 (110 μg/kg bw/day), and their mixture; P < 0.05 (*)
Effect of DON on DNA fragmentation in blood lymphocytes of mice
We next evaluated fragmentation of the DNA of blood lymphocytes cells by agarose gel electrophoresis. There was an increase in DNA fragmentation as evidenced by the appearance of DNA ladders [Figure 3]. The sizes of DNA fragments appear to be above 250 bp in majority.
Figure 3.

Agarose gel electrophoresis of DNA extracted from kidney cells after treatment of mice (only females) by DON at dose of 45 μg/kg bw/day. Lane 1 = Ladder, Lane 2 = control mice, Lane 3 = DON
DISCUSSION
In our previous study performed on Caco-2 cells line, we have reported that the mixtures of Fusarium mycotoxins zearalenone, FB1, and DON tested at low levels (10 μM for each mycotoxin); led to additive, antagonism, or synergistic effect.[5] These results should be confirmed by in vivo test. Thus, in the present study, we use low levels of FB1 (110 μg/kg bw/day) and DON (45 μg/kg bw/day) defined following the concentrations of 10 μM previously used in our in vitro study.[5,14] Moreover, after an examination of toxicity data relevant for hazard characterization for DON, it had been proposed a tolerable daily Intake (TDI) of 1 μg/kg bw for DON[15] which might correspond to 100 μg/kg bw for experimental animals. More recently, in a study on induction of food refusal by DON, it has been reported that the no-observed adverse effect level (NOAEL) for DON is 0.5 and 1.0 mg/kg bw following intraperitoneal (ip) and oral exposure, respectively.[7] The doses of DON and FB1 used in the previous both studies were higher than those used in the present study, so the toxic effects induced by DON and FB1 or their mixture could be considered as precocious effects. An analysis of results showed that general toxic effects of DON and FB1 appeared at very low doses of 45 μg/kg bw/day and 110 μg/kg bw/day for DON and FB1, respectively. Regarding the body weight, female mice have been found more sensitive comparatively to males mice, but this decreasing weight seems to be explaining by the reduction in food intake. In blood biochemistry examinations, the significant elevation of TC and TGs induced by both DON and FB1 and their mixture revealed a plausible lipid and lipoprotein (elevation of serum proteins) metabolism disorders for all animals treated. In addition, the elevation of AST and ALT for female mice could mean a slight liver cell lyses which were more marked for female mice. But, for all mice treated by both mycotoxins and their mixture, we also observed elevation of rhabdomyolysis biomarker CK[16] which combined to elevation of AST but not for ALT (more specific to liver damage) could signify massive destruction of muscular tissue.[16] These observations should be confirmed by histological examinations.
On the other hand, we observed an evident elevation of serum creatinine which was in correlation with decrease of unary creatinine. Similarly, serum TPs were increased; but we observed a decrease of unary TPs. The renal clearances of creatinine for all mice treated (females and males) by FB1 and FB1 + DON (but not DON alone) were twice or four times inferior in comparison to those of control mice [Table 4]. These observations revealed evident disorders in renal filtration caused by mycotoxin FB1 and its association with DON. Our results were supported by previous studies focused on FB1, FB2, and FB3 performed in rats and mice.[17,18] But macroscopic examinations did not reveal damage of the kidney of mice treated by FB1 and FB1 + DON. However, we think that a prolongation of duration of our experiments in order to show an evident damage of kidney induced by FB1 and DON tested at very low doses should lead to marked histopathological effects. In the meantime and in order to preliminarily explore mechanism of such kidney toxicity and regarding in vitro high DNA methylation induced by mycotoxins DON and FB1,[14] we projected to determine whether DON, FB1, and their mixtures provoke DNA methylation in kidney cells. Surprisingly, our results revealed high DNA methylation by DON (not FB1) and more intensively by DON + FB1. Evidently, FB1 enhanced toxic action of DON which confirmed its in vitro effect on DNA methylation in intestinal cells line Caco-2.[5,14] However, this DNA methylation in kidney cells was not linked to renal filtration because FB1 did not impact on DNA methylation, but has been found an effective toxic for renal filtration in contrast to DON. Previously, it had been reported that DNA methylation elevation could be linked to radical oxygen species (ROS) produced by oxidative stress.[19] In fact, the lipid, proteins, or specially DNA oxidation induced by ROS could lead to elevation of DNA methylation.[5,19] In addition, the oxidation of cell membrane lipids led to loss of maintenance of cell homeostasis or cell death by necrosis. Thus, by a high oxidative stress induced in the kidney cells, DON and its association with FB1 induced an elevation of serum CK which is a consequence of the destruction of the kidney tissue by necrosis.[8,20,21] Moreover, the methylation of DNA revealed the capability of DON to provoke early in vivo DNA modifications or damage. Thus, an examination of blood lymphocytes DNA has been performed specially for DON. The DNA fragmentation induced by DON confirmed not only its precocious toxic action in immune system,[19] but its tendency to impact negatively cell DNA in vivo.
Table 4.
Renal clearance by serum and unary creatinine, (Ccr (ml/min) ×10-4) for females and males mice after oral treatment by DON (45 μg/kg bw/day), FB1 (110 μg/kg bw/day), and their mixture; P<0.05 (*)

CONCLUSION
The oral repetitive administration of low dose of DON and FB1 during only 7 days has revealed disorders in lipid metabolism, renal filtration disturb and renal cell DNA methylation, rhabdomyolysis, and blood lymphocytes cell deaths. These effects could be considering as precocious effect of both mycotoxins DON and FB1 in mice. Female mice were more sensitive and the mixture of DON and FB1 led to additive or more than additive effect as previous reported.[18] Finally, our results demonstrated that the NOAEL of both DON and FB1 were low than 45 μg/kg bw/day and 110 μg/kg bw/day, respectively and these doses were lower than those previously reported.[7,22]
Footnotes
Source of Support: Nil.
Conflict of Interest: None declared.
REFERENCES
- 1.Price WD, Lovell RA, McChesney DG. Naturally occurring toxins in feedstuffs: Center for Veterinary medicine perspective. J Anim Sci. 1993;71:2556–62. doi: 10.2527/1993.7192556x. [DOI] [PubMed] [Google Scholar]
- 2.Dawlatana M, Coker RD, Nagler MJ, Wild CP, Hassan MS, Blunden G. The occurrence of mycotoxins in key commodities in Bangladesh: Surveillance results from 1993 to 1995. J Nat Toxins. 2002;11:379–86. [PubMed] [Google Scholar]
- 3.Boeira LS, Bryce JH, Stewart GG, Flannigan B. The effect of combinations of Fusarium mycotoxins (deoxynivalenol, zearalenon and fumonisin B1) on growth of brewing yeasts. J Appl Microbiol. 2000;88:388–403. doi: 10.1046/j.1365-2672.2000.00972.x. [DOI] [PubMed] [Google Scholar]
- 4.Tajima O, Schoen ED, Feron VJ, Groten JP. Statistically designed experiments in a tiered approach to screen mixtures of Fusarium mycotoxins for possible interactions. Food Chem Toxicol. 2002;40:685–95. doi: 10.1016/s0278-6915(01)00124-7. [DOI] [PubMed] [Google Scholar]
- 5.Kouadio JH, Dano SD, Moukha S, Mobio TA, Creppy EE. Effects of combinations of Fusarium mycotoxins on the inhibition of macromolecular synthesis, malondialdehyde levels, DNA methylation and fragmentation, and viability in Caco-2 cells. Toxicon. 2007;49:306–17. doi: 10.1016/j.toxicon.2006.09.029. [DOI] [PubMed] [Google Scholar]
- 6.Creppy EE. Update of survey, regulation and toxic effects of mycotoxins in Europe. Toxicol Lett. 2002;127:19–28. doi: 10.1016/s0378-4274(01)00479-9. [DOI] [PubMed] [Google Scholar]
- 7.Flannery BM, Wu W, Pestka JJ. Characterization of Deoxynivalenol-Induced anorexia using mouse bioassay. Food Chem Toxicol. 2011;49:1863–9. doi: 10.1016/j.fct.2011.05.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Young LG, McGirr L, Valli VE, Lumsden JH, Lun A. Vomitoxin in corn fed to young pigs. J Anim Sci. 1983;57:655–64. doi: 10.2527/jas1983.573655x. [DOI] [PubMed] [Google Scholar]
- 9.Iverson F, Armstrong C, Nera E, Truelove J, Fernie S, Scott P, et al. Chronic feeding study of deoxynivalenol in B6C3F1 male and female mice. Teratog Carcinog Mutagen. 1995;15:283–306. doi: 10.1002/(SICI)1520-6866(1996)15:6<283::AID-TCM5>3.0.CO;2-E. [DOI] [PubMed] [Google Scholar]
- 10.Bucci TJ, Howard PC, Tolleson WH, Laborde JB, Hansen DK. Renal effects of fumonisin mycotoxins in animals. Toxicol Pathol. 1998;26:160–4. doi: 10.1177/019262339802600119. [DOI] [PubMed] [Google Scholar]
- 11.Edrington TS, Kamps-Holtzapple CA, Harvey RB, Kubena LF, Elissalde MH, Rottinghaus GE. Acute hepatic and renal toxicity in lambs dosed with fumonisin containing culture material. J Anim Sci. 1995;73:508–15. doi: 10.2527/1995.732508x. [DOI] [PubMed] [Google Scholar]
- 12.Matias WG, Creppy EE. 5-Methyldeoxycytosine as a biological marker of DNA damage induced by okadaıc acidin Vero cells. Environ Toxicol Water Qual. 1998;13:83–7. [Google Scholar]
- 13.Gad SC, Neil CS. Statistics for toxicologists. In: Hayes AW, editor. Principles and Methods of Toxicology. New York: Raven Press; 1982. p. 273. [Google Scholar]
- 14.Kubena LF, Edrington TS, Harvey RB, Buckley SA, Phillips TD, Rottinghaus GE, et al. Individual and combined effects of fumonisin B 1 present in Fusarium moniliforme culture material and T-2 toxin or deoxynivalenol in broiler chicks. Poult Sci. 1997;76:1239–47. doi: 10.1093/ps/76.9.1239. [DOI] [PubMed] [Google Scholar]
- 15.Schlatter J. Toxicity data relevant for hazard characterization. Toxicol Lett. 2004;153:83–9. doi: 10.1016/j.toxlet.2004.04.025. [DOI] [PubMed] [Google Scholar]
- 16.Lehmann P, Hartung W, Fleck M. Rhabdomyolysis and creatine kinase elevation. Z Rheumatol. 2013;72:236–41. doi: 10.1007/s00393-012-1081-x. [DOI] [PubMed] [Google Scholar]
- 17.Voss KA, Riley RT, Norred WP, Bacon CW, Meredith FI, Howard PC, et al. Subchronic toxic effects of Fusarium moniliforme and fumonisin B1 in rats and mice. Nat Toxins. 1996;4:16–23. doi: 10.1002/19960401nt3. [DOI] [PubMed] [Google Scholar]
- 18.Voss KA, Plattner RD, Riley RT, Meredith FI, Norred WP. In vivo effects of fumonisin B1-producing and fumonisin B1-nonproducing Fusarium moniliforme isolates are similar: Fumonisins B2 and B3 cause hepato- and nephrotoxicity in rats. Mycopathologia. 1998;141:45–58. doi: 10.1023/a:1006810916344. [DOI] [PubMed] [Google Scholar]
- 19.Mobio TA, Anane R, Baudrimont I, Carratú MR, Shier TW, Dano SD, et al. Epigenetic properties of fumonisin B (1): Cell cycle arrest and DNA base modification in C6 glioma cells. Toxicol Appl Pharmacol. 2000;164:91–6. doi: 10.1006/taap.2000.8893. [DOI] [PubMed] [Google Scholar]
- 20.el-Ashker MR. Acute kidney injury mediated by oxidative stress in Egyptian horses with exertional rhabdomyolysis. Vet Res Commun. 2011;35:311–20. doi: 10.1007/s11259-011-9475-9. [DOI] [PubMed] [Google Scholar]
- 21.Herráez García J, Torracchi Carrasco AM, Antolí-Royo AC, de la Fuente Blanco R, Santos Jiménez MT. Rhabdomyolysis. A descriptive study of 449 patients. Med Clin (Barc) 2012;139:238–42. doi: 10.1016/j.medcli.2011.05.021. [DOI] [PubMed] [Google Scholar]
- 22.Riley RT, Enongene E, Voss KA, Norred WP, Meredith FI, Sharma RP, et al. Sphingolipid perturbations as mechanisms for fumonisin carcinogenesis. Environ Health Perspect. 2001;109:3018. doi: 10.1289/ehp.01109s2301. [DOI] [PMC free article] [PubMed] [Google Scholar]
